Adam R Wolfe

6PUBLICATIONS
10CO-AUTHORS
Cancer cell biologyOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 01, 2024
Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions.

Adam R Wolfe, Tiantian Cui, Sooin Baie

|Sep 25, 2023
Erratum: Clinical Outcomes and Multidisciplinary Patterns of Failure for Olfactory Neuroblastoma: The Ohio State Experience.

Adam R Wolfe, Dukagjin Blakaj, Nyall London

|Oct 22, 2020
Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer.

Adam R Wolfe, Ryan Robb, Ahmad Hegazi

|Jun 06, 2020
Clinical Outcomes and Multidisciplinary Patterns of Failure for Olfactory Neuroblastoma: The Ohio State Experience.

Adam R Wolfe, Dukagjin Blakaj, Nyall London

|May 17, 2020
Neoadjuvant-modified FOLFIRINOX vs nab-paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection.

Adam R Wolfe, Dhivya Prabhakar, Vedat O Yildiz

|May 18, 2019
Inhibiting BRAF Oncogene-Mediated Radioresistance Effectively Radiosensitizes BRAFV600E-Mutant Thyroid Cancer Cells by Constraining DNA Double-Strand Break Repair.

Ryan Robb, Linlin Yang, Changxian Shen

Pageof 1

Frequent Collaborators

3 joint publications

Terence M Williams

1 joint publications

Motoyasu Saji

1 joint publications

Sooin Baie

1 joint publications

Sergio Corrales-Guerrero